HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrizia Ferroni Selected Research

Precision Medicine

1/2019Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine.
1/2017Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrizia Ferroni Research Topics

Disease

49Neoplasms (Cancer)
04/2021 - 01/2003
18Venous Thromboembolism
03/2021 - 11/2012
14Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 01/2003
12Migraine Disorders (Migraine)
01/2020 - 09/2013
11Inflammation (Inflammations)
09/2016 - 06/2003
9Breast Neoplasms (Breast Cancer)
08/2018 - 09/2009
6Thrombosis (Thrombus)
12/2013 - 03/2004
5Neoplasm Metastasis (Metastasis)
02/2017 - 01/2003
5Atherosclerosis
12/2014 - 06/2003
4Headache (Headaches)
01/2019 - 01/2015
4Cardiovascular Diseases (Cardiovascular Disease)
05/2013 - 02/2008
4Essential Hypertension
07/2012 - 02/2008
4Hypercholesterolemia
08/2004 - 06/2003
3Hemorrhage
05/2020 - 01/2015
3Obesity
07/2017 - 05/2014
3Type 2 Diabetes Mellitus (MODY)
07/2017 - 05/2013
3Pain (Aches)
05/2017 - 01/2015
3Stroke (Strokes)
01/2015 - 06/2011
3Activated Protein C Resistance (APC Resistance)
09/2013 - 11/2012
3Lung Neoplasms (Lung Cancer)
11/2012 - 01/2003
3Hypertension (High Blood Pressure)
07/2012 - 03/2008
3Myocardial Infarction
06/2007 - 09/2003
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2006 - 01/2003
2Prescription Drug Overuse
08/2019 - 01/2017
2Disease Progression
01/2018 - 09/2004
2Thromboembolism
01/2017 - 01/2010
2Triple Negative Breast Neoplasms
10/2016 - 01/2016
2Insulin Resistance
01/2016 - 01/2015
2Heart Diseases (Heart Disease)
12/2014 - 04/2004
2Sarcoma (Soft Tissue Sarcoma)
05/2013 - 07/2012
2Genetic Predisposition to Disease (Genetic Predisposition)
06/2011 - 09/2009
2Fibrosis (Cirrhosis)
02/2011 - 09/2002
2Chest Pain (Chest Pains)
06/2007 - 04/2004
2Atherosclerotic Plaque (Atheroma)
09/2003 - 06/2003
1Microsatellite Instability
01/2021

Drug/Important Bio-Agent (IBA)

13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 01/2003
9CytokinesIBA
01/2019 - 01/2003
9SelectinsIBA
02/2011 - 01/2003
7Pharmaceutical PreparationsIBA
01/2020 - 03/2007
7Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2012
6Bevacizumab (Avastin)FDA Link
07/2017 - 01/2010
6Protein CIBA
01/2016 - 01/2010
5LipidsIBA
01/2017 - 06/2003
5ThrombinFDA Link
11/2016 - 01/2004
5DNA (Deoxyribonucleic Acid)IBA
01/2016 - 09/2009
5CD40 Ligand (CD40L)IBA
05/2013 - 06/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2012 - 09/2002
4Glucose (Dextrose)FDA LinkGeneric
07/2017 - 01/2015
4Insulin (Novolin)FDA Link
07/2017 - 05/2013
4Oxidants (Oxidizing Agents)IBA
02/2017 - 08/2004
4PlatinumIBA
10/2014 - 06/2011
4fibrin fragment D (D-dimer)IBA
03/2014 - 01/2003
4C-Reactive ProteinIBA
03/2008 - 06/2003
4P-SelectinIBA
03/2008 - 01/2004
3Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 12/2013
3AnticoagulantsIBA
05/2020 - 01/2015
3AdipokinesIBA
01/2019 - 08/2009
3Biological ProductsIBA
08/2018 - 06/2003
3AntioxidantsIBA
01/2018 - 06/2011
3Blood Glucose (Blood Sugar)IBA
07/2017 - 01/2016
3Messenger RNA (mRNA)IBA
10/2016 - 06/2010
3VaccinesIBA
10/2016 - 05/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2015 - 06/2011
3EnzymesIBA
01/2015 - 04/2004
3AdiponectinIBA
05/2014 - 01/2007
3ParaffinIBA
01/2014 - 07/2012
3Carcinoembryonic AntigenIBA
06/2010 - 01/2003
3Fibrinogen (Factor I)FDA Link
04/2004 - 06/2003
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 09/2016
2Dopamine beta-HydroxylaseIBA
08/2019 - 01/2015
2NeuropeptidesIBA
01/2019 - 05/2017
2Peptides (Polypeptides)IBA
01/2019 - 05/2013
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
07/2017 - 12/2016
2Phenobarbital (Luminal)FDA Link
02/2017 - 10/2016
2Brachyury protein (Brachyury)IBA
10/2016 - 05/2014
2Transcription Factors (Transcription Factor)IBA
10/2016 - 05/2014
2ThromboxanesIBA
09/2016 - 08/2011
2Hormones (Hormone)IBA
01/2016 - 05/2014
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2014 - 05/2013
2Fluorouracil (Carac)FDA LinkGeneric
09/2014 - 12/2013
2LeptinIBA
05/2014 - 08/2009
2Plasminogen Activator Inhibitor 1IBA
03/2014 - 09/2009
2Hemostatics (Antihemorrhagics)IBA
05/2013 - 06/2003
2Thromboxane A2 (A2, Thromboxane)IBA
05/2013 - 08/2011
2Antihypertensive Agents (Antihypertensives)IBA
07/2012 - 02/2008
2Cytotoxins (Cytolysins)IBA
06/2011 - 03/2007
2E-SelectinIBA
06/2010 - 01/2003
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2009 - 10/2003
2von Willebrand FactorIBA
03/2008 - 01/2005
2Interleukin-6 (Interleukin 6)IBA
06/2007 - 01/2003
2antithrombin III-protease complexIBA
01/2004 - 01/2003
2InterleukinsIBA
10/2003 - 09/2003
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2003 - 01/2003
1Circulating Tumor DNAIBA
12/2020
1Antineoplastic Agents (Antineoplastics)IBA
05/2020
1Fibrinolytic Agents (Antithrombotic Agents)IBA
05/2020

Therapy/Procedure

20Therapeutics
04/2021 - 03/2004
19Drug Therapy (Chemotherapy)
01/2021 - 08/2006
2Treatment Delay
03/2021 - 01/2019
2Precision Medicine
01/2019 - 01/2017